National Research (NRC)
(Delayed Data from NSDQ)
$22.80 USD
+0.52 (2.33%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $22.78 -0.02 (-0.09%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for National Research Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 7 | 25 | 54 | 35 | 14 |
Receivables | 13 | 15 | 14 | 15 | 12 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 5 | 4 | 5 | 4 | 4 |
Total Current Assets | 24 | 44 | 74 | 54 | 29 |
Net Property & Equipment | 28 | 17 | 12 | 12 | 14 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 1 | 2 | 4 | 5 | 4 |
Intangibles | 63 | 63 | 63 | 59 | 60 |
Deposits & Other Assets | 3 | 3 | 3 | 3 | 3 |
Total Assets | 122 | 130 | 158 | 133 | 111 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 7 | 4 | 4 | 4 | 4 |
Accounts Payable | 1 | 1 | 2 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 9 | 9 | 13 | 10 | 9 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 19 | 19 | 22 | 17 | 23 |
Total Current Liabilities | 36 | 33 | 40 | 32 | 38 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 4 | 5 | 7 | 7 | 7 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 29 | 18 | 22 | 27 | 30 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 2 | 3 | 4 | 2 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 73 | 58 | 72 | 69 | 78 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 178 | 175 | 174 | 172 | 162 |
Retained Earnings | -31 | -25 | -36 | -61 | -93 |
Other Equity | 0 | 0 | -2 | -2 | -2 |
Treasury Stock | 99 | 78 | 50 | 44 | 34 |
Total Shareholder's Equity | 49 | 72 | 85 | 64 | 33 |
Total Liabilities & Shareholder's Equity | 122 | 130 | 158 | 133 | 111 |
Total Common Equity | 49 | 72 | 85 | 64 | 33 |
Shares Outstanding | 24.20 | 24.60 | 25.30 | 25.30 | 24.90 |
Book Value Per Share | 2.02 | 2.93 | 3.37 | 2.54 | 1.32 |
Fiscal Year End for National Research Corporation falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 0 | 2 | 7 | 4 | 23 |
Receivables | 10 | 11 | 13 | 15 | 12 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 6 | 7 | 5 | 6 | 6 |
Total Current Assets | 17 | 20 | 24 | 25 | 41 |
Net Property & Equipment | 34 | 32 | 28 | 26 | 23 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 1 | 1 | 1 | 2 | 2 |
Intangibles | 63 | 63 | 63 | 63 | 63 |
Deposits & Other Assets | 2 | 3 | 3 | 4 | 5 |
Total Assets | 119 | 121 | 122 | 120 | 134 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 17 | 15 | 7 | 10 | 5 |
Accounts Payable | 1 | 2 | 1 | 1 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 10 | 11 | 9 | 10 | 8 |
Income Taxes Payable | 0 | 2 | 0 | 0 | 0 |
Other Current Liabilities | 18 | 19 | 19 | 20 | 19 |
Total Current Liabilities | 46 | 49 | 36 | 41 | 34 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 4 | 4 | 4 | 5 | 5 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 26 | 28 | 29 | 14 | 15 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 4 | 4 | 3 | 2 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 79 | 84 | 73 | 62 | 56 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 180 | 180 | 178 | 177 | 177 |
Retained Earnings | -24 | -27 | -31 | -36 | -17 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 116 | 116 | 99 | 82 | 82 |
Total Shareholder's Equity | 40 | 37 | 49 | 58 | 78 |
Total Liabilities & Shareholder's Equity | 119 | 121 | 122 | 120 | 134 |
Total Common Equity | 40 | 37 | 49 | 58 | 78 |
Shares Outstanding | 23.80 | 23.80 | 24.20 | 24.50 | 24.50 |
Book Value Per Share | 1.69 | 1.55 | 2.02 | 2.36 | 3.17 |